Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
GAD65 is one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein.
Gene Name: | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) |
Synonyms: | GAD2, GAD-65, Glutamate decarboxylase 2, GAD65 |
Target Sequences: | NM_000818 NP_000809.1 Q05329 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.